HF Advisory Group LLC Takes $1.52 Million Position in Healthpeak Properties, Inc. $DOC

HF Advisory Group LLC purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 103,744 shares of the real estate investment trust’s stock, valued at approximately $1,517,000.

Several other large investors have also bought and sold shares of DOC. Mather Group LLC. bought a new position in Healthpeak Properties in the third quarter valued at approximately $25,000. City Holding Co. bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $26,000. Sound Income Strategies LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $28,000. Rexford Capital Inc. bought a new position in shares of Healthpeak Properties in the 2nd quarter worth $28,000. Finally, Elevation Point Wealth Partners LLC bought a new position in shares of Healthpeak Properties in the 2nd quarter worth $32,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on DOC shares. Evercore reduced their price target on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Wells Fargo & Company restated a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Citigroup dropped their price target on Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating on the stock in a research report on Wednesday. Six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $19.27.

Healthpeak Properties Stock Performance

NYSE DOC opened at $16.53 on Friday. The stock has a market cap of $11.49 billion, a PE ratio of 165.27, a P/E/G ratio of 8.77 and a beta of 1.10. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The firm has a 50-day moving average of $17.10 and a 200-day moving average of $17.46. Healthpeak Properties, Inc. has a 52-week low of $15.71 and a 52-week high of $20.10.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The business had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. Healthpeak Properties’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a $0.1017 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.4%. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.